Endocrinology, Vol 128, 1238-1246, Copyright © 1991 by Endocrine Society

ARTICLES

Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH

JM Orian, K Snibson, JL Stevenson, MR Brandon and AC Herington
Department of Veterinary Preclinical Sciences, University of Melbourne, Parkville, Victoria, Australia.

The effect of elevated serum ovine GH (oGH) concentration on liver somatotrophic and lactogenic receptors was studied in transgenic mice expressing a metallothionein 1(MT)-oGH fusion gene. The mice belonged to three different pedigrees and were killed between 14 and 63 weeks of age. The levels of GH receptor (GH-R) and PRL receptor (PRL-R) determined by competitive binding assays were similar to those observed in late pregnant, nontransgenic mice. This observation was made for all transgenic mice expressing elevated serum oGH levels, irrespective of sex, final size, or age. Cross-linking studies revealed that binding occurred predominantly to a Mr 48,000 polypeptide with a small amount of binding to polypeptides of Mr 60,000, 70,000, and 100,000 in transgenic mice as well as in a late pregnant, nontransgenic mouse. Total cellular RNA was isolated from livers of transgenic and nontransgenic mice and analyzed on Northern blots using probes specific for GH-R and PRL-R. Results showed that the levels of messenger RNA for both GH-R and PRL-R were elevated in transgenic mice expressing high levels of serum oGH. Since levels of PRL in these mice were within the normal range, these results demonstrate that oGH is capable of inducing hepatic GH-R and PRL-R in vivo and that PRL is not required for the induction of its own receptor. These data also demonstrate, for the first time, the suitability of transgenic mice expressing a foreign GH for the study of the regulation of hepatic GH and PRL receptors.

This article has been cited by other articles:

				M. L Rise, S. E Douglas, D. Sakhrani, J. Williams, K V. Ewart, M. Rise, W. S Davidson, B. F Koop, and R. H Devlin Multiple microarray platforms utilized for hepatic gene expression profiling of GH transgenic coho salmon with and without ration restriction. J. Mol. Endocrinol., October 1, 2006; 37(2): 259 - 282. [Abstract] [Full Text] [PDF]

				B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511. [Abstract] [Full Text] [PDF]

				C. Ling, G. Hellgren, M. Gebre-Medhin, K. Dillner, H. Wennbo, B. Carlsson, and H. Billig Prolactin (PRL) Receptor Gene Expression in Mouse Adipose Tissue: Increases during Lactation and in PRL-Transgenic Mice Endocrinology, October 1, 2000; 141(10): 3564 - 3572. [Abstract] [Full Text] [PDF]

				A. Bartke, V. Chandrashekar, D. Turyn, R. W. Steger, L. Debeljuk, T. A. Winters, J. A. Mattison, N. A. Danilovich, W. Croson, D. R. Wernsing, et al. Effects of Growth Hormone Overexpression and Growth Hormone Resistance on Neuroendocrine and Reproductive Functions in Transgenic and Knock-Out Mice Experimental Biology and Medicine, November 1, 1999; 222(2): 113 - 123. [Abstract] [Full Text]

				A. Ikeda, K.-T. Chang, Y. Matsumoto, Y. Furuhata, M. Nishihara, F. Sasaki, and M. Takahashi Obesity and Insulin Resistance in Human Growth Hormone Transgenic Rats Endocrinology, July 1, 1998; 139(7): 3057 - 3063. [Abstract] [Full Text] [PDF]

				T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat Endocrinology, February 1, 1997; 138(2): 580 - 587. [Abstract] [Full Text] [PDF]